Regen BioPharma Inc (RGBP)

[OTCShotCaller]

RGBP's NR2F6 Patent Entering Next Phase Toward FDA Approval

https://www.stocktitan.net/news/ONPH/oncology-pharma-inc-is-entering-into-the-next-phase-of-its-growth-msgem1hjj0hb.html

SAN FRANCISCO, CA /June 30, 2021 / Oncology Pharma Inc(the "Company") is developing a program to establish the use of its license utilizing NR2F6 agonists and antagonists coupled with the proprietary drug delivery systems in the treatment of various disorders including human pancreatic cancer and colon cancer.

The work the Company is contracting to conduct is intended to do pre-clinical trials leading into seeking FDA approval for the combined efforts.

Our team of industry experts and advisors have the expertise to lead the Company to efficiently conduct this next phase of development. The developing program will allow Oncology Pharma to begin its own path towards producing proprietary intellectual property,for the pursuit and development of new therapies.

The Company's established portfolio of licensing agreements is expected to allow the company the ability to develop its own innovations to stand out amongst its peers.

Sounds like we're on the right track and this is only the beginning as several or our other Patents are being revived by Koos.

Keep in mind RGBP is now officially a revenue generating company via the closure of its licensing deal with Oncology Pharma, totally unheard of anywhere on the OTC!

Just wait until the Quarterly Revenues begin to fall to our bottom line Q over Q.

Be well and prosper...